173 related articles for article (PubMed ID: 11858875)
1. Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin.
Sheoran AS; Artiushin S; Timoney JF
Vaccine; 2002 Feb; 20(11-12):1653-9. PubMed ID: 11858875
[TBL] [Abstract][Full Text] [Related]
2. Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system.
Nally JE; Artiushin S; Sheoran AS; Burns PJ; Simon B; Gilley RM; Gibson J; Sullivan S; Timoney JF
Vaccine; 2000 Oct; 19(4-5):492-7. PubMed ID: 11027813
[TBL] [Abstract][Full Text] [Related]
3. Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses.
Sheoran AS; Sponseller BT; Holmes MA; Timoney JF
Vet Immunol Immunopathol; 1997 Nov; 59(3-4):239-51. PubMed ID: 9477475
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses.
Flock M; Jacobsson K; Frykberg L; Hirst TR; Franklin A; Guss B; Flock JI
Infect Immun; 2004 Jun; 72(6):3228-36. PubMed ID: 15155624
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with a live multi-gene deletion strain protects horses against virulent challenge with Streptococcus equi.
Robinson C; Heather Z; Slater J; Potts N; Steward KF; Maskell DJ; Fontaine MC; Lee JJ; Smith K; Waller AS
Vaccine; 2015 Feb; 33(9):1160-7. PubMed ID: 25597942
[TBL] [Abstract][Full Text] [Related]
6. Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection.
Guss B; Flock M; Frykberg L; Waller AS; Robinson C; Smith KC; Flock JI
PLoS Pathog; 2009 Sep; 5(9):e1000584. PubMed ID: 19763180
[TBL] [Abstract][Full Text] [Related]
7. Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi.
Timoney JF; Qin A; Muthupalani S; Artiushin S
Vaccine; 2007 Jul; 25(30):5583-90. PubMed ID: 17360081
[TBL] [Abstract][Full Text] [Related]
8. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response.
Soboll G; Nelson KM; Leuthner ES; Clark RJ; Drape R; Macklin MD; Swain WF; Olsen CW; Lunn DP
Vaccine; 2003 Jun; 21(21-22):3081-92. PubMed ID: 12798652
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse.
Flock M; Karlström A; Lannergård J; Guss B; Flock JI
Vaccine; 2006 May; 24(19):4144-51. PubMed ID: 16580099
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a commercially available modified-live Streptococcus equi subsp equi vaccine in ponies.
Borst LB; Patterson SK; Lanka S; Barger AM; Fredrickson RL; Maddox CW
Am J Vet Res; 2011 Aug; 72(8):1130-8. PubMed ID: 21801073
[TBL] [Abstract][Full Text] [Related]
11. Characterization and protective immunogenicity of the SzM protein of Streptococcus zooepidemicus NC78 from a clonal outbreak of equine respiratory disease.
Velineni S; Timoney JF
Clin Vaccine Immunol; 2013 Aug; 20(8):1181-8. PubMed ID: 23740925
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunogenicity of a Deltacya Deltacrp-pabA mutant of Salmonella enterica serotype Typhimurium for the horse.
Sheoran AS; Timoney JF; Tinge SA; Sundaram P; Curtiss R
Vaccine; 2001 May; 19(25-26):3591-9. PubMed ID: 11348727
[TBL] [Abstract][Full Text] [Related]
13. Antibody kinetics and immune profile analysis of a Streptococcus equi DNA vaccine expressing the FljB and SeM fusion protein in murine and equine models.
Ma X; Wang C; Zhang B; Xia L; Su Y
Res Vet Sci; 2019 Aug; 125():82-88. PubMed ID: 31174167
[TBL] [Abstract][Full Text] [Related]
14. Affects of N-terminal variation in the SeM protein of Streptococcus equi on antibody and fibrinogen binding.
Timoney JF; DeNegri R; Sheoran A; Forster N
Vaccine; 2010 Feb; 28(6):1522-7. PubMed ID: 20005857
[TBL] [Abstract][Full Text] [Related]
15. Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi.
Robinson C; Frykberg L; Flock M; Guss B; Waller AS; Flock JI
Vaccine; 2018 Mar; 36(11):1484-1490. PubMed ID: 29398274
[TBL] [Abstract][Full Text] [Related]
16. Novel Streptococcus equi strains causing strangles outbreaks in Arabian horses in Egypt.
Tartor YH; El-Naenaeey EY; Gharieb NM; Ali WS; Ammar AM
Transbound Emerg Dis; 2020 Nov; 67(6):2455-2466. PubMed ID: 32304282
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of horses against strangles using recombinant antigens from Streptococcus equi.
Waller A; Flock M; Smith K; Robinson C; Mitchell Z; Karlström A; Lannergård J; Bergman R; Guss B; Flock JI
Vaccine; 2007 May; 25(18):3629-35. PubMed ID: 17321016
[TBL] [Abstract][Full Text] [Related]
18. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
[TBL] [Abstract][Full Text] [Related]
19. Characterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi.
Artiushin SC; Timoney JF; Sheoran AS; Muthupalani SK
Microb Pathog; 2002 Feb; 32(2):71-85. PubMed ID: 11812213
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.
Wozniak A; Scioscia N; García PC; Dale JB; Paillavil BA; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM
Microbiol Immunol; 2018 Jun; 62(6):395-404. PubMed ID: 29704396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
